
Retatrutide 40mg
This item is currently unavailable.
£124.00
Research overview
Retatrutide is a synthetic peptide investigational compound designed as a triple agonist at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors.
It is used in laboratory receptor-binding, cell-signalling, and pharmacology assays to study incretin pathway biology. Retatrutide is not an approved pharmaceutical product and must not be used outside qualified research environments.
Scientific identity
- Designation
- Retatrutide
- Class
- Triple GIP / GLP-1 / glucagon receptor agonist (research compound)
- Form
- Lyophilised powder
Areas of laboratory research
- Incretin receptor binding and signalling assays
- Metabolic pathway research in cell lines
- Comparative pharmacology of multi-agonist peptides
- Bioanalytical method development (LC-MS, ELISA)
Vial contents & storage
Contents: One lyophilised research vial (40 mg), supplied for individual laboratory use.
Storage: Lyophilised material: store at ≤-20°C. If reconstituted, store at 2–8°C.
Supplied strictly for in vitro laboratory research. Not for human or veterinary administration, diagnosis, or therapeutic use.